SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2 | -87.5% | 2,396 | -78.5% | 0.00% | – |
| Q4 2023 | $16 | -42.9% | 11,122 | -6.0% | 0.00% | – |
| Q3 2023 | $28 | -50.9% | 11,835 | 0.0% | 0.00% | – |
| Q2 2023 | $57 | +3.6% | 11,835 | +21.2% | 0.00% | – |
| Q1 2023 | $55 | -12.7% | 9,768 | -13.1% | 0.00% | -100.0% |
| Q4 2022 | $63 | -99.9% | 11,244 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +89.5% | 11,244 | +1.6% | 0.00% | – |
| Q2 2022 | $38,000 | -53.1% | 11,065 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -60.3% | 11,332 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $204,000 | +131.8% | 24,576 | +94.6% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -71.9% | 12,626 | -3.9% | 0.00% | -66.7% |
| Q2 2021 | $313,000 | +48.3% | 13,143 | +52.5% | 0.00% | -62.5% |
| Q4 2020 | $211,000 | -9.8% | 8,621 | +4.4% | 0.01% | -20.0% |
| Q3 2020 | $234,000 | – | 8,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
| Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
| Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
| Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
| FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
| Knott David M Jr | 110,000 | $706,000 | 0.30% |
| Atom Investors LP | 108,820 | $699,000 | 0.25% |
| Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
| HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |